---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-021927"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:21:23.779891+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Provectus Biopharma provides annual meeting update, slides attached

## Summary
- Update covers clinical development, regulatory, drug discovery, manufacturing, IP, business and corporate development.
- Presentation slides filed as Exhibit 99.1 but not reproduced; specific details not available in this filing summary.
- No financial results, guidance, or milestones disclosed in the 8-K body; rely on the attached slides for materiality.
- Filing under Regulation FD; information is furnished, not filed.

## SEC filing metadata
- accession: 0001493152-23-021927
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315223021927/0001493152-23-021927-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315223021927/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-021927
- JSON: https://secwatch.observer/filing/0001493152-23-021927.json
- Plain text: https://secwatch.observer/filing/0001493152-23-021927.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.